Rare and complex connective tissue diseases (rCTDs) encompass a considerable number of diseases and syndromes and their variability highly impacts on the clinical management, resulting in variable economic and organisational burden that might represent a challenge for healthcare systems. This paper is aimed at providing an overview of the most recent evidence regarding the economic and organisational impact of rCTDs. In particular, this work discusses the most relevant data on specific aspects related to health economics in rCTDs published in 2019.
|Titolo:||One year in review 2020: economic and organisational aspects in rare and complex connective tissue diseases|
|Data di pubblicazione:||2020|
|Appare nelle tipologie:||1.1 Articolo su Rivista/Article|